NEW YORK (GenomeWeb) – Mental health-focused genetic testing firm Genomind today said that it closed a $6 million funding round.

The latest investment bid was led by Claritas Capital, which led a $5 million financing round for Genomind in April 2014.

In a statement, Genomind said it plans to use the infusion of funds to grow the firm, conduct multisite randomized trials for the Genecept Assay pharmacogenetic service, and develop a new, expanded test offering. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.